{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:51:19Z","timestamp":1782226279142,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metab"],"DOI":"10.1186\/s40170-025-00381-7","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:52:47Z","timestamp":1741099967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Obesity and overweight in R\/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8\u2009+\u2009cells and vitamin D"],"prefix":"10.1186","volume":"13","author":[{"given":"Lourdes","family":"Hontecillas-Prieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Garc\u00eda-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Jim\u00e9nez-Cortegana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Nogales-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Palaz\u00f3n-Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Mart\u00edn","family":"Garc\u00eda-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"R\u00edos-Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Gum\u00e0-Padr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Provencio-Pulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rueda-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"de la Cruz-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"S\u00e1nchez-Margalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"381_CR1","doi-asserted-by":"publisher","first-page":"1293931","DOI":"10.3389\/fimmu.2024.1293931","volume":"15","author":"L Hontecillas-Prieto","year":"2024","unstructured":"Hontecillas-Prieto L, Garc\u00eda-Dom\u00ednguez DJ, Palaz\u00f3n-Carri\u00f3n N, Mart\u00edn Garc\u00eda-Sancho A, Nogales-Fern\u00e1ndez E, Jim\u00e9nez-Cortegana C, et al. CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent\/refractory diffuse large B cell lymphoma. Front Immunol. 2024;15:1293931.","journal-title":"Front Immunol"},{"key":"381_CR2","doi-asserted-by":"crossref","unstructured":"Jimenez-Cortegana C, Sanchez-Martinez PM, Palazon-Carrion N, Nogales-Fernandez E, Henao-Carrasco F, Martin Garcia-Sancho A, et al. Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed\/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial. Cancers. 2021;13(18).","DOI":"10.3390\/cancers13184622"},{"key":"381_CR3","doi-asserted-by":"crossref","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625\u201338.","DOI":"10.1056\/NEJMoa021423"},{"issue":"16","key":"381_CR4","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.ejca.2011.06.029","volume":"47","author":"SC Larsson","year":"2011","unstructured":"Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin\u2019s and Hodgkin\u2019s lymphoma: a meta-analysis of prospective studies. Eur J Cancer. 2011;47(16):2422\u201330.","journal-title":"Eur J Cancer"},{"key":"381_CR5","doi-asserted-by":"crossref","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers. 2023;15(2).","DOI":"10.3390\/cancers15020485"},{"issue":"3","key":"381_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.3520","volume":"4","author":"F Petrelli","year":"2021","unstructured":"Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O, et al. Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021;4(3): e213520.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"381_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170311","volume":"12","author":"IY Chung","year":"2017","unstructured":"Chung IY, Lee JW, Lee JS, Park YR, Min YH, Lee Y, et al. Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer. PLoS ONE. 2017;12(3): e0170311.","journal-title":"PLoS One"},{"issue":"2","key":"381_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3945\/ajcn.112.044859","volume":"97","author":"AE Arthur","year":"2013","unstructured":"Arthur AE, Peterson KE, Rozek LS, Taylor JM, Light E, Chepeha DB, et al. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis. Am J Clin Nutr. 2013;97(2):360\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"381_CR9","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/MLG.0b013e31816fca5c","volume":"118","author":"TR McRackan","year":"2008","unstructured":"McRackan TR, Watkins JM, Herrin AE, Garrett-Mayer EM, Sharma AK, Day TA, et al. Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008;118(7):1180\u20135.","journal-title":"Laryngoscope"},{"key":"381_CR10","doi-asserted-by":"crossref","unstructured":"Jimenez-Cortegana C, Lopez-Saavedra A, Sanchez-Jimenez F, Perez-Perez A, Castineiras J, Virizuela-Echaburu JA, et al. Leptin, Both Bad and Good Actor in Cancer. Biomolecules. 2021;11(6).","DOI":"10.3390\/biom11060913"},{"issue":"12","key":"381_CR11","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/cncr.25114","volume":"116","author":"SM Geyer","year":"2010","unstructured":"Geyer SM, Morton LM, Habermann TM, Allmer C, Davis S, Cozen W, et al. Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer. 2010;116(12):2993\u20133000.","journal-title":"Cancer"},{"issue":"26","key":"381_CR12","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1200\/JCO.2011.39.2100","volume":"30","author":"KR Carson","year":"2012","unstructured":"Carson KR, Bartlett NL, McDonald JR, Luo S, Zeringue A, Liu J, et al. Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. J Clin Oncol. 2012;30(26):3217\u201322.","journal-title":"J Clin Oncol"},{"issue":"1","key":"381_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/annonc\/mdt481","volume":"25","author":"L Weiss","year":"2014","unstructured":"Weiss L, Melchardt T, Habringer S, Boekstegers A, Hufnagl C, Neureiter D, et al. Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma. Annals of oncology\u202f: official journal of the European Society for Medical Oncology. 2014;25(1):171\u20136.","journal-title":"Annals Oncol"},{"issue":"17","key":"381_CR14","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1158\/1078-0432.CCR-22-0588","volume":"28","author":"N Palazon-Carrion","year":"2022","unstructured":"Palazon-Carrion N, Martin Garcia-Sancho A, Nogales-Fernandez E, Jimenez-Cortegana C, Carnicero-Gonzalez F, Rios-Herranz E, et al. Lenalidomide plus R-GDP (R2-GDP) in Relapsed\/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis. Clin Cancer Res. 2022;28(17):3658\u201368.","journal-title":"Clin Cancer Res"},{"key":"381_CR15","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1\u2013253."},{"issue":"5","key":"381_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol"},{"issue":"16","key":"381_CR17","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800\u20138.","journal-title":"Blood"},{"issue":"13","key":"381_CR18","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/cncr.34718","volume":"129","author":"L Galus","year":"2023","unstructured":"Galus L, Michalak M, Lorenz M, Stoinska-Swiniarek R, Tusien Malecka D, Galus A, et al. Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD-1 therapy. Cancer. 2023;129(13):2047\u201355.","journal-title":"Cancer"},{"issue":"2","key":"381_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clml.2013.10.005","volume":"14","author":"JJ Castillo","year":"2014","unstructured":"Castillo JJ, Ingham RR, Reagan JL, Furman M, Dalia S, Mitri J. Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Clin Lymphoma Myeloma Leuk. 2014;14(2):122\u201330.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"381_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2018.03.031","volume":"98","author":"T Aparicio","year":"2018","unstructured":"Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, et al. Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials. Eur J Cancer. 2018;98:1\u20139.","journal-title":"Eur J Cancer"},{"key":"381_CR21","doi-asserted-by":"crossref","unstructured":"Icard P, Schussler O, Loi M, Bobbio A, Lupo AM, Wislez M, et al. Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor Stage. Cancers. 2020;12(2).","DOI":"10.3390\/cancers12020266"},{"key":"381_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3389\/fonc.2019.00596","volume":"9","author":"F Sanchez-Jimenez","year":"2019","unstructured":"Sanchez-Jimenez F, Perez-Perez A, de la Cruz-Merino L, Sanchez-Margalet V. Obesity and Breast Cancer: Role of Leptin. Front Oncol. 2019;9:596.","journal-title":"Front Oncol"},{"key":"381_CR23","doi-asserted-by":"crossref","unstructured":"Jimenez-Cortegana C, Palazon-Carrion N, Martin Garcia-Sancho A, Nogales-Fernandez E, Carnicero-Gonzalez F, Rios-Herranz E, et al. Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory\/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial. J Immunother Cancer. 2021;9(6).","DOI":"10.1136\/jitc-2020-002323"},{"issue":"3","key":"381_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3892\/or_00000924","volume":"24","author":"A Bojarska-Junak","year":"2010","unstructured":"Bojarska-Junak A, Hus I, Sieklucka M, Wasik-Szczepanek E, Mazurkiewicz T, Polak P, et al. Natural killer-like T CD3+\/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome. Oncol Rep. 2010;24(3):803\u201310.","journal-title":"Oncol Rep"},{"issue":"34","key":"381_CR25","doi-asserted-by":"publisher","first-page":"55222","DOI":"10.18632\/oncotarget.10484","volume":"7","author":"LS Peng","year":"2016","unstructured":"Peng LS, Mao FY, Zhao YL, Wang TT, Chen N, Zhang JY, et al. Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer. Oncotarget. 2016;7(34):55222\u201330.","journal-title":"Oncotarget"},{"key":"381_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fimmu.2017.00643","volume":"8","author":"G Donninelli","year":"2017","unstructured":"Donninelli G, Del Corno M, Pierdominici M, Scazzocchio B, Vari R, Varano B, et al. Distinct Blood and Visceral Adipose Tissue Regulatory T Cell and Innate Lymphocyte Profiles Characterize Obesity and Colorectal Cancer. Front Immunol. 2017;8:643.","journal-title":"Front Immunol"},{"issue":"3","key":"381_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/oby.20087","volume":"21","author":"NM Wagner","year":"2013","unstructured":"Wagner NM, Brandhorst G, Czepluch F, Lankeit M, Eberle C, Herzberg S, et al. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring). 2013;21(3):461\u20138.","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"381_CR28","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1634\/theoncologist.2012-0169","volume":"17","author":"E Del Fabbro","year":"2012","unstructured":"Del Fabbro E, Parsons H, Warneke CL, Pulivarthi K, Litton JK, Dev R, et al. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist. 2012;17(10):1240\u20135.","journal-title":"Oncologist"},{"issue":"25","key":"381_CR29","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1200\/JCO.2007.14.4527","volume":"26","author":"JK Litton","year":"2008","unstructured":"Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, et al. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol. 2008;26(25):4072\u20137.","journal-title":"J Clin Oncol"},{"issue":"10","key":"381_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204729","volume":"13","author":"G Richtig","year":"2018","unstructured":"Richtig G, Hoeller C, Wolf M, Wolf I, Rainer BM, Schulter G, et al. Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study. PLoS ONE. 2018;13(10): e0204729.","journal-title":"PLoS ONE"},{"issue":"1","key":"381_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","volume":"7","author":"A Cortellini","year":"2019","unstructured":"Cortellini A, Bersanelli M, Buti S, Cannita K, Santini D, Perrone F, et al. A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable. J Immunother Cancer. 2019;7(1):57.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"381_CR32","first-page":"75","volume":"17","author":"S Atak","year":"2023","unstructured":"Atak S, Serin S, Demirel N, Dogan EE, Aydin D, Nizam N, et al. The Obesity Controversy: Does It Impact Treatment Response in Diffuse Large B-Cell Lymphoma? Int J Hematol Oncol Stem Cell Res. 2023;17(2):75\u201380.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"5","key":"381_CR33","first-page":"271","volume":"11","author":"PR Fuchshuber","year":"1992","unstructured":"Fuchshuber PR, Lotzova E. Differential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures. Lymphokine Cytokine Res. 1992;11(5):271\u20136.","journal-title":"Lymphokine Cytokine Res"},{"issue":"9","key":"381_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1292\/jvms.65.995","volume":"65","author":"K Kushima","year":"2003","unstructured":"Kushima K, Fujita M, Shigeta A, Horiuchi H, Matsuda H, Furusawa S. Flow cytometric analysis of chicken NK activity and its use on the effect of restraint stress. J Vet Med Sci. 2003;65(9):995\u20131000.","journal-title":"J Vet Med Sci"},{"issue":"4","key":"381_CR35","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1046\/j.1365-2141.2002.03495.x","volume":"117","author":"MW Lowdell","year":"2002","unstructured":"Lowdell MW, Craston R, Samuel D, Wood ME, O\u2019Neill E, Saha V, et al. Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. Br J Haematol. 2002;117(4):821\u20137.","journal-title":"Br J Haematol"},{"issue":"9","key":"381_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.bmt.1700756","volume":"19","author":"MW Lowdell","year":"1997","unstructured":"Lowdell MW, Ray N, Craston R, Corbett T, Deane M, Prentice HG. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Bone Marrow Transplant. 1997;19(9):891\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"381_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/cyto.990110316","volume":"11","author":"EF Srour","year":"1990","unstructured":"Srour EF, Leemhuis T, Jenski L, Redmond R, Jansen J. Cytolytic activity of human natural killer cell subpopulations isolated by four-color immunofluorescence flow cytometric cell sorting. Cytometry. 1990;11(3):442\u20136.","journal-title":"Cytometry"},{"issue":"21","key":"381_CR38","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.1128\/JVI.01420-14","volume":"88","author":"F Ahmad","year":"2014","unstructured":"Ahmad F, Hong HS, Jackel M, Jablonka A, Lu IN, Bhatnagar N, et al. High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression. J Virol. 2014;88(21):12397\u2013408.","journal-title":"J Virol"},{"issue":"13","key":"381_CR39","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1073\/pnas.0711558105","volume":"105","author":"S Yu","year":"2008","unstructured":"Yu S, Cantorna MT. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A. 2008;105(13):5207\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"381_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1365-2249.1999.00855.x","volume":"116","author":"E Mariani","year":"1999","unstructured":"Mariani E, Ravaglia G, Forti P, Meneghetti A, Tarozzi A, Maioli F, et al. Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol. 1999;116(1):19\u201327.","journal-title":"Clin Exp Immunol"},{"issue":"1\u20136","key":"381_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0022-4731(89)90120-9","volume":"34","author":"JM Quesada","year":"1989","unstructured":"Quesada JM, Solana R, Martin A, Santamaria M, Serrano I, Martinez ME, et al. The effect of calcitriol on natural killer cell activity in hemodialyzed patients. J Steroid Biochem. 1989;34(1\u20136):423\u20135.","journal-title":"J Steroid Biochem"},{"key":"381_CR42","doi-asserted-by":"crossref","unstructured":"Bruns H, Buttner M, Fabri M, Mougiakakos D, Bittenbring JT, Hoffmann MH, et al. Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma. Sci Transl Med. 2015;7(282):282ra47.","DOI":"10.1126\/scitranslmed.aaa3230"},{"issue":"11","key":"381_CR43","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00262-018-2224-y","volume":"67","author":"F Neumann","year":"2018","unstructured":"Neumann F, Acker F, Schormann C, Pfreundschuh M, Bittenbring JT. Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity. Cancer immunology, immunotherapy\u202f: CII. 2018;67(11):1709\u201318.","journal-title":"Cancer immunology, immunotherapy : CII"},{"issue":"1","key":"381_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clnu.2020.04.040","volume":"40","author":"P Chen","year":"2021","unstructured":"Chen P, Cao Y, Duan X, Li J, Zhao W, Wang H. Bioavailable 25(OH)D level is associated with clinical outcomes of patients with diffuse large B-cell lymphoma: An exploratory study. Clin Nutr. 2021;40(1):157\u201365.","journal-title":"Clin Nutr"},{"issue":"7","key":"381_CR45","doi-asserted-by":"publisher","first-page":"300060520943421","DOI":"10.1177\/0300060520943421","volume":"48","author":"V Graklanov","year":"2020","unstructured":"Graklanov V, Popov V. Vitamin D levels in patients with non-Hodgkin lymphoma\/diffuse large B-cell lymphoma, chronic lymphocytic leukemia and multiple myeloma. J Int Med Res. 2020;48(7):300060520943421.","journal-title":"J Int Med Res"},{"issue":"13","key":"381_CR46","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1200\/JCO.2014.57.5092","volume":"33","author":"JL Kelly","year":"2015","unstructured":"Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, et al. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies. J Clin Oncol. 2015;33(13):1482\u201390.","journal-title":"J Clin Oncol"},{"issue":"4","key":"381_CR47","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00432-020-03125-w","volume":"146","author":"DM Xu","year":"2020","unstructured":"Xu DM, Liang JH, Wang L, Zhu HY, Xia Y, Fan L, et al. 25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma. J Cancer Res Clin Oncol. 2020;146(4):1003\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"381_CR48","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","volume":"34","author":"G Salles","year":"2017","unstructured":"Salles G, Barrett M, Foa R, Maurer J, O\u2019Brien S, Valente N, et al. Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience. Adv Ther. 2017;34(10):2232\u201373.","journal-title":"Adv Ther"},{"issue":"8","key":"381_CR49","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/annonc\/mdv102","volume":"26","author":"TE Witzig","year":"2015","unstructured":"Witzig TE, Nowakowski GS, Habermann TM, Goy A, Hernandez-Ilizaliturri FJ, Chiappella A, et al. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma. Annals of oncology\u202f: official journal of the European Society for Medical Oncology. 2015;26(8):1667\u201377.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"issue":"8","key":"381_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.346","volume":"5","author":"C Brosseau","year":"2014","unstructured":"Brosseau C, Dousset C, Touzeau C, Maiga S, Moreau P, Amiot M, et al. Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK. Cell Death Dis. 2014;5(8): e1389.","journal-title":"Cell Death Dis"},{"issue":"1","key":"381_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/cam4.1166","volume":"7","author":"S Hohaus","year":"2018","unstructured":"Hohaus S, Tisi MC, Bellesi S, Maiolo E, Alma E, Tartaglia G, et al. Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy. Cancer Med. 2018;7(1):270\u201381.","journal-title":"Cancer Med"}],"container-title":["Cancer & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-025-00381-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40170-025-00381-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-025-00381-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:51:09Z","timestamp":1741103469000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerandmetabolism.biomedcentral.com\/articles\/10.1186\/s40170-025-00381-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1186\/s40170-025-00381-7","relation":{},"ISSN":["2049-3002"],"issn-type":[{"value":"2049-3002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted according to the International Ethical Guidelines for Biomedical Research Involving Human Subjects, the Declaration of Helsinki, good clinical practice guidelines, and local laws. The study protocol, along with any subsequent amendments, received approval from the Seville Provincial Ethics Committee for Research with Drugs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}